A Serum Small Molecule Biosignature of Radiation Exposure from Total Body Irradiated Patients

• Published in: Journal of proteome research Vol. 16; no. 10; pp. 3805 - 3815
• Main Authors: Laiakis, Evagelia C, Pannkuk, Evan L, Chauthe, Siddheshwar Kisan, Wang, Yi-Wen, Lian, Ming, Mak, Tytus D, Barker, Christopher A, Astarita, Giuseppe, Fornace, Albert J
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 06.10.2017
• Subjects: eicosanoids; metabolomics; inflammation; serum; humans; lipidomics; ionizing radiation
• ISSN: 1535-3893; 1535-3907
• DOI: 10.1021/acs.jproteome.7b00468

The potential for radiological accidents and nuclear terrorism has increased the need for the development of new rapid biodosimetry methods. In addition, in a clinical setting the issue of an individual’s radiosensitivity should be taken into consideration during radiotherapy. We utilized metabolomics and lipidomics to investigate changes of metabolites in serum samples following exposure to total body ionizing radiation in humans. Serum was collected prior to irradiation, at 3–8 h after a single dose of 1.25–2 Gy, and at 24 h with a total delivered dose of 2–3.75 Gy. Metabolomics revealed perturbations in glycerophosphocholine, phenylalanine, ubiquinone Q2, and oxalic acid. Alterations were observed in circulating levels of lipids from monoacylglycerol, triacylglycerol, phosphatidylcholine, and phosphatidylglycerol lipid classes. Polyunsaturated fatty acids were some of the most dysregulated lipids, with increased levels linked to proinflammatory processes. A targeted metabolomics approach for eicosanoids was also employed. The results showed a rapid response for proinflammatory eicosanoids, with a dampening of the signal at the later time point. Sex differences were observed in the markers from the untargeted approach but not the targeted method. The ability to identify and quantify small molecules in blood can therefore be utilized to monitor radiation exposure in human populations.